Pediatric Experts Sound Alarm Over Rapid Rise in Melatonin Use and Lack of Long Term Safety Data for Children

Doctors warn that melatonin use in kids is rising faster than safety data, citing concerns over hormone disruption, mislabeling, and accidental ingestions.

By: AXL Media

Published: Mar 16, 2026, 4:28 AM EDT

Source: Information for this report was sourced from Zhejiang University

The Growing Mismatch Between Popularity and Evidence

Melatonin has evolved into one of the most frequently administered sleep aids for children globally, largely fueled by the perception that it is a natural and benign solution for insomnia. However, a comprehensive narrative review published in the World Journal of Pediatrics suggests that the surge in usage has far exceeded the scientific community’s understanding of its long term impact. Researchers indicate that while the supplement is often marketed as a simple sleep aid, melatonin is a potent biologically active hormone that influences the immune system, metabolism, and reproductive processes. This rapid adoption without sufficient clinical oversight has raised significant questions about the potential for unintended physiological consequences in developing bodies.

Efficacy in Neurodevelopmental Versus Typical Populations

The clinical evidence for melatonin is not uniform across all pediatric groups, creating a complex landscape for parents and clinicians. Strong data supports the short term use of the hormone for children with neurodevelopmental conditions such as ADHD and autism, where it effectively reduces the time taken to fall asleep and improves caregiver quality of life. Conversely, for typically developing children, the evidence remains strikingly limited and inconsistent. Most randomized trials have focused on adolescents or older children over brief periods, leaving a significant data gap regarding the effects on younger children who are increasingly being given the supplement by their parents.

Hidden Risks of Mislabeled Supplements and Contamination

A primary concern highlighted in the research involves the lack of regulatory oversight governing the production of over the counter melatonin. Independent testing of commercial products has revealed alarming discrepancies between the dosage listed on the label and the actual concentration found within the supplement. Some products were found to contain several times the stated dose, while others were contaminated with unexpected compounds such as serotonin. This inconsistency makes it nearly impossible for parents to provide a controlled and safe dosage, potentially exposing children to much higher levels of the hormone than intended by their healthcare providers.